Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
Condition:   Fontan Palliation Interventions:   Drug: Tadalafil;   Drug: Placebo Sponsors:   Mayo Clinic;   National Heart, Lung, and Blood Institute (NHLBI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2022 Category: Research Source Type: clinical trials